Prevalence of Clinical Signs Within Reference Ranges Among Hospitalized Patients Prescribed Antibiotics for Pneumonia.


Journal

JAMA network open
ISSN: 2574-3805
Titre abrégé: JAMA Netw Open
Pays: United States
ID NLM: 101729235

Informations de publication

Date de publication:
01 07 2020
Historique:
entrez: 18 7 2020
pubmed: 18 7 2020
medline: 22 12 2020
Statut: epublish

Résumé

Antibiotics are frequently prescribed for suspected pneumonia, but overdiagnosis is common and fixed regimens are often used despite randomized trials suggesting it is safe to stop antibiotics once clinical signs are normalizing. To quantify potential excess antibiotic prescribing by characterizing antibiotic use relative to patients' initial clinical signs and subsequent trajectories. An observational cohort study was conducted in 2 tertiary and 2 community hospitals in Eastern Massachusetts. All nonventilated adult patients admitted between May 1, 2017, and July 1, 2018 (194 521 hospitalizations), were included. Identification of all antibiotic starts for possible community-acquired pneumonia (CAP) or hospital-acquired pneumonia (HAP) per clinicians' stated indications. Potential excess antibiotic prescribing was quantified by characterizing the frequency of patients in whom all clinical signs were within reference ranges on the first day of antibiotic therapy and by how long antibiotic therapy was continued after all clinical signs were normal, including postdischarge antibiotics. Among 194 521 hospitalizations, 9540 patients were treated for possible CAP (4574 [48.0%] women; mean [SD] age, 67.6 [17.0] years) and 2733 for possible HAP (1211 [44.3%] women; mean [SD] age, 66.7 [16.2] years). Temperature, respiratory rate, oxygen saturation, and white blood cell count were all within reference ranges on the first day of antibiotics in 1779 of 9540 (18.6%) episodes of CAP and 370 of 2733 (13.5%) episodes of HAP. Antibiotics were continued for 3 days or longer after all clinical signs were normal in 3322 of 9540 (34.8%) episodes of CAP and 1050 of 2733 (38.4%) episodes of HAP. Up to 24 978 of 71 706 (34.8%) antibiotic-days prescribed for possible pneumonia may have been unnecessary. In this study, almost one-fifth of hospitalized patients treated for pneumonia did not have any of the cardinal signs of pneumonia on the first day of treatment and antibiotics were continued for 3 days or longer after all signs were normal in more than a third of patients. These observations suggest substantial opportunities to improve antibiotic prescribing.

Identifiants

pubmed: 32678449
pii: 2768346
doi: 10.1001/jamanetworkopen.2020.10700
pmc: PMC7368172
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Journal Article Observational Study Research Support, U.S. Gov't, P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2010700

Références

JAMA. 2007 Apr 11;297(14):1583-93
pubmed: 17426278
Age Ageing. 2016 Jan;45(1):171-4
pubmed: 26683049
Histopathology. 2005 Dec;47(6):551-9
pubmed: 16324191
Lancet. 2012 Jan 14;379(9811):136-42
pubmed: 22112684
Arch Intern Med. 2009 Sep 14;169(16):1525-31
pubmed: 19752411
Clin Radiol. 2004 Aug;59(8):743-52
pubmed: 15262550
MMWR Morb Mortal Wkly Rep. 2014 Mar 7;63(9):194-200
pubmed: 24598596
Clin Infect Dis. 2018 Apr 17;66(9):1333-1341
pubmed: 29126268
Ann Am Thorac Soc. 2019 Apr;16(4):426-429
pubmed: 30883190
Am J Med. 2004 Sep 1;117(5):305-11
pubmed: 15336579
Clin Infect Dis. 2016 Sep 1;63(5):e61-e111
pubmed: 27418577
JAMA. 1997 Nov 5;278(17):1440-5
pubmed: 9356004
Ann Intern Med. 2019 Aug 6;171(3):153-163
pubmed: 31284301
Lancet Infect Dis. 2018 Jan;18(1):95-107
pubmed: 29037960
S Afr Med J. 2016 Jan 06;106(2):196-200
pubmed: 26821903
Lancet Respir Med. 2018 Jan;6(1):40-50
pubmed: 29196046
Clin Infect Dis. 2007 Mar 1;44 Suppl 2:S27-72
pubmed: 17278083
Am J Respir Crit Care Med. 2017 Oct 1;196(7):856-863
pubmed: 28345952
Thorax. 2017 Apr;72(4):376-379
pubmed: 28108620
J Hosp Infect. 2016 Mar;92(3):273-9
pubmed: 26810613
JAMA. 2014 Oct 8;312(14):1438-46
pubmed: 25291579
JAMA. 2018 Oct 9;320(14):1433-1434
pubmed: 30242350
N Engl J Med. 2017 Jun 8;376(23):2235-2244
pubmed: 28528569
J Chronic Dis. 1987;40(5):373-83
pubmed: 3558716
Lancet Infect Dis. 2014 Dec;14(12):1220-7
pubmed: 25455989
Am J Respir Crit Care Med. 2019 Oct 1;200(7):e45-e67
pubmed: 31573350
BMJ. 2006 Jun 10;332(7554):1355
pubmed: 16763247
J Hosp Infect. 2018 Jul;99(3):312-317
pubmed: 29621601
J Crit Care. 2010 Mar;25(1):62-8
pubmed: 19592209
Am J Respir Crit Care Med. 2000 Aug;162(2 Pt 1):505-11
pubmed: 10934078
Ann Intern Med. 2000 Apr 18;132(8):621-30
pubmed: 10766680
Chest. 1996 Aug;110(2):343-50
pubmed: 8697831
Pharmacoepidemiol Drug Saf. 2013 Aug;22(8):834-41
pubmed: 23554109
Am J Respir Crit Care Med. 2015 Oct 15;192(8):974-82
pubmed: 26168322
BMJ Open. 2015 Aug 27;5(8):e008424
pubmed: 26316651
Lancet Infect Dis. 2012 Oct;12(10):774-80
pubmed: 22951600
Arch Intern Med. 1994 Dec 12-26;154(23):2729-32
pubmed: 7993157
Med Care. 1998 Jan;36(1):8-27
pubmed: 9431328

Auteurs

Michael Klompas (M)

Harvard Pilgrim Health Care Institute, Department of Population Medicine, Harvard Medical School, Boston, Massachusetts.
Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.

Aileen Ochoa (A)

Harvard Pilgrim Health Care Institute, Department of Population Medicine, Harvard Medical School, Boston, Massachusetts.

Wenjing Ji (W)

Harvard Pilgrim Health Care Institute, Department of Population Medicine, Harvard Medical School, Boston, Massachusetts.
Department of Pharmacy Administration and Clinical Pharmacy, Xi'an Jiaotong University School of Pharmacy, Xi'an, Shaanxi, China.

Caroline McKenna (C)

Harvard Pilgrim Health Care Institute, Department of Population Medicine, Harvard Medical School, Boston, Massachusetts.

Roger Clark (R)

Department of Medicine, Brigham and Women's Faulkner Hospital, Boston, Massachusetts.

Erica S Shenoy (ES)

Infection Control Unit, Massachusetts General Hospital, Boston, Massachusetts.

David Hooper (D)

Infection Control Unit, Massachusetts General Hospital, Boston, Massachusetts.

Chanu Rhee (C)

Harvard Pilgrim Health Care Institute, Department of Population Medicine, Harvard Medical School, Boston, Massachusetts.
Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH